What is the Future of Molecular Markers in Cancer Research?
The field of molecular markers in cancer is rapidly evolving. Advances in next-generation sequencing and other high-throughput technologies are enabling the discovery of new biomarkers at an unprecedented rate. Additionally, the integration of artificial intelligence and machine learning in data analysis is expected to uncover complex biomarker signatures that can improve diagnosis, prognosis, and treatment strategies.
